A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax).
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System
- Status
- COMPLETED
- Phase
- NA
Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Trial of MSC1936369B in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Of SU14813 In Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055
- Status
- COMPLETED
- Phase
- PHASE1
Study of KRN951 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
- Status
- TERMINATED
- Phase
- PHASE1
Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- NA
Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors
- Status
- TERMINATED
- Phase
- PHASE4
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1